ISIN | LU1660425346 |
---|---|
Valor Number | 37774288 |
Bloomberg Global ID | |
Fund Name | DNB Fund-Health Care Retail A (EUR) |
Fund Provider |
DNB Asset Management AS
Stockholm, Sweden Phone: +46 8 473 41 00 Web: www.cim.se |
Fund Provider | DNB Asset Management AS |
Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributor(s) |
Allfunds International Schweiz AG
DZ Private Bank (schweiz) AG
Fund Channel (Suisse) SA Nyon 2 Phone: +4122 0000 Swissquote Bank Gland Phone: +41 22 999 94 11 UBS AG Zürich Phone: +41 44 234 11 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Emphasis is placed on investments in the equities of companies operating in or associated with the health care sectors. Geographically the Sub-Fund has full flexibility. The Sub-Fund may invest between 5% and 15% of its net assets in equities quoted on the Hong Kong Stock exchange or on the Shanghai Stock exchange. |
Peculiarities |
Current Price * | 14.95 EUR | 30.06.2025 |
---|---|---|
Previous Price * | 14.95 EUR | 27.06.2025 |
52 Week High * | 18.37 EUR | 30.08.2024 |
52 Week Low * | 14.83 EUR | 22.04.2025 |
NAV * | 14.95 EUR | 30.06.2025 |
Issue Price * | 14.95 EUR | 30.06.2025 |
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 97,065,947 | |
Unit/Share Assets *** | 172,980 | |
Trading Information SIX |
YTD Performance | -11.87% |
31.12.2024 - 30.06.2025
31.12.2024 30.06.2025 |
---|---|---|
YTD Performance (in CHF) | -12.39% |
31.12.2024 - 30.06.2025
31.12.2024 30.06.2025 |
1 month | -1.97% |
30.05.2025 - 30.06.2025
30.05.2025 30.06.2025 |
3 months | -10.01% |
31.03.2025 - 30.06.2025
31.03.2025 30.06.2025 |
6 months | -11.50% |
30.12.2024 - 30.06.2025
30.12.2024 30.06.2025 |
1 year | -14.85% |
01.07.2024 - 30.06.2025
01.07.2024 30.06.2025 |
2 years | -8.34% |
30.06.2023 - 30.06.2025
30.06.2023 30.06.2025 |
3 years | -5.27% |
30.06.2022 - 30.06.2025
30.06.2022 30.06.2025 |
5 years | +13.81% |
30.06.2020 - 30.06.2025
30.06.2020 30.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 7.05% | |
---|---|---|
AstraZeneca PLC | 6.45% | |
Roche Holding AG | 6.22% | |
Novo Nordisk AS Class B | 6.15% | |
Johnson & Johnson | 6.03% | |
Lonza Group Ltd | 3.77% | |
UnitedHealth Group Inc | 3.48% | |
Sanofi SA | 3.26% | |
DexCom Inc | 3.24% | |
Thermo Fisher Scientific Inc | 3.03% | |
Last data update | 31.05.2025 |
TER *** | 1.605% |
---|---|
TER date *** | 31.03.2025 |
Performance Fee *** | 20.00% |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.60% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |